First patient dosed in REVEAL pivotal trial evaluating TSHA-102 (N=15, aged 6 to <22 years) in Q4 2025, with enrollment ...
WiMi Releases Next-Generation Quantum Convolutional Neural Network Technology for Multi-Channel Supervised Learning BEIJING, Jan. 05, 2026––WiMi Hologram Cloud Inc. (NASDAQ: WiMi) ("WiMi" or the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback